ClinicalTrials.gg
Not yet recruitingNCT07858240TACTICEUpdated Oct 5, 2026

The Impact of Long-term Isolation in Antarctica on Social Touch and Its Underlying Biological Mechanisms in Winter-over Crew Members, Assessed During Their Stay Using Standardized Touch Stimulation, Computer-based Touch Sensitivity Tests, Questionnaires and Biological Markers.

An observational study in Social Isolation and Isolated Confined and Extreme Conditions, sponsored by Vrije Universiteit Brussel. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-05.

Sponsored by Vrije Universiteit Brussel · Observational

How we know

Updated Oct 5, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
28
Ages
18 Years and older
Sex
All
01

Study summary

TACTICE investigates how long-term isolation and reduced social touch during an Antarctic winter-over affect the way people perceive and respond to touch. The study will follow winter-over crew members at Concordia Station in Antarctica during the 2027 and 2028 seasons.

The study focuses on so-called C-tactile (CT) sensitivity. CT afferents are specialized nerve fibers in the skin that are known to be involved in the pleasant and regulatory effects of social touch. They may also play a role in how prolonged social isolation affects people during a long-term mission in an isolated, confined, and extreme (ICE) environment.

Participants will be assessed repeatedly before, during and after their stay. CT sensitivity will be measured using standardized touch stimulation and computer-based tasks involving touch-related stimuli. Participants will also complete questionnaires on social touch, loneliness, stress, relationships and coping. Saliva and blood samples will be collected to measure biological markers related to stress regulation and social processes, including cortisol and oxytocin.

The main hypothesis is that prolonged isolation and reduced opportunities for social touch change CT sensitivity and reduce an important source of stress regulation. These changes are expected to become more pronounced with time spent at the station and to be related to changes in stress responses, behaviour, attitudes and interpersonal functioning. The study aims to improve understanding of how people adapt to prolonged isolation and confinement and may help inform the planning of future long-duration missions in remote and extreme environments, including space missions.

02

Conditions studied

  • Social Isolation
  • Isolated Confined and Extreme Conditions

Browse trials for

03

In context

Social Isolation

237 studies on the registry are indexed under Social Isolation; 61 are open to participants now.

This study's planned enrollment of 28 is below the median of 200 across 35 observational studies indexed under Social Isolation.

Browse Social Isolation studies →

Lead sponsor

Vrije Universiteit Brussel is the lead sponsor of 160 studies on the registry; 43 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Winter-over Crew members in Concordia Station in Antarctica

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Member of the Concordia Station winter-over crew for the 2027 or 2028 Antarctic winter-over season and willing to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • No study-specific exclusion criteria.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
28 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna

Interventions

  • OtherNo Intervention: Observational Cohort

    TACTICE is considered an observational study because the exposure of interest(i.e., long-term isolation and confinement during an Antarctic winter-over at Concordia Station) is not assigned by the study investigators. Participants are winter-over crew members who will stay at Concordia independently of their participation in TACTICE. The study follows this predefined cohort prospectively and repeatedly over time to observe changes in CT sensitivity, stress-related biological markers, behaviour, attitudes and interpersonal functioning. The protocol therefore describes TACTICE as a "longitudinal study with a naturalistic design. The standardized touch stimulation, computer-based tasks, questionnaires, saliva sampling and blood sampling are used as study assessments to measure outcomes over time and not as therapeutic or diagnostic interventions.

06

What researchers measure

Primary outcomes

  1. Change in experiential C-tactile (CT) sensitivity assessed by pleasantness and intensity ratings on a Visual Analog Scale ranging from -10 to +10 using the Manual Tactile Stimulator.

    Experiential CT sensitivity will be assessed using standardized stroking touch, delivered with a mechanic Manual Tactile Stimulator tool to the forearm and palm at three velocities (0.3, 3, and 30 cm/s), using smooth and ribbed probe surfaces. Participants rate perceived pleasantness and intensity on a Visual Analog Scale ranging from -10 to +10. Changes in VAS scores across repeated assessments will be used to characterize experiential CT sensitivity over time.

    Time frame: Baseline (approximately 2-3 months before departure); Month 1, Month 4, Month 7, Month 10, and Month 12 during the Antarctic winter-over; 6 months post-mission; and 2 years post-mission.

  2. Change in vicarious C-tactile (CT) sensitivity assessed by pleasantness and intensity ratings on a Visual Analog Scale ranging from -10 to +10 using the Vicarious Touch Task

    Vicarious CT sensitivity will be assessed using standardized 6-second videos depicting interpersonal touch at different body locations and velocities. Participants rate the perceived pleasantness and intensity of the observed touch on a Visual Analog Scale ranging from -10 to +10. Changes in ratings across repeated assessments will be used to characterize vicarious CT sensitivity over time.

    Time frame: Baseline (approximately 2-3 months before departure); Month 1, Month 4, Month 7, Month 10, and Month 12 during the Antarctic winter-over; 6 months post-mission; and 2 years post-mission.

Secondary outcomes

  1. Change in behavioral C-tactile (CT) sensitivity assessed by interpersonal space boundary using the Footstep Task with response time in milliseconds (ms).

    Interpersonal space boundary will be assessed using an auditory stop-distance paradigm. Participants listen to approaching footsteps and press a key when the approaching person makes them feel uncomfortable. The outcome measure is the response time in milliseconds (ms) from stimulus onset to the stop response. Changes in response time across repeated assessments will be used as an indirect behavioral measure associated with CT sensitivity.

    Time frame: Baseline (approximately 2-3 months before departure); Month 1, Month 4, Month 7, Month 10, and Month 12 during the Antarctic winter-over; 6 months post-mission; and 2 years post-mission.

  2. Change in neurobiophysiological C-tactile (CT) sensitivity assessed by salivary cortisol concentration (µg/L) measured by saliva sampling and analyses

    Salivary cortisol concentration concentration will be measured as a neuroendocrine marker of HPA-axis stress regulation associated with C-tactile (CT)-mediated touch. Saliva samples are collected on one combined sampling evening and morning per month. One sample is collected before bedtime and three samples are collected in the following morning: immediately after awakening, 30 minutes after awakening, and 60 minutes after awakening. Cortisol concentrations (µg/L) and the cortisol awakening response (CAR) will be evaluated across repeated assessments over time.

    Time frame: Baseline (approximately 2-3 months before departure); monthly during the Antarctic winter-over; 6 months post-mission; and 2 years post-mission.

  3. Change in neurobiophysiological C-tactile (CT) sensitivity assessed by plasma oxytocin concentration (pg/ml) measured by blood sampling and analyses

    Plasma oxytocin concentration will be measured from blood samples as a neuroendocrine marker associated with affiliative social touch and the rewarding neurobiology of C-tactile (CT)-mediated touch. Changes in plasma oxytocin concentration (pg/ml) will be evaluated across repeated assessments over time.

    Time frame: Baseline (approximately 2-3 months before departure); Month 1, Month 4, Month 7, Month 10, and Month 12 during the Antarctic winter-over; 6 months post-mission; and 2 years post-mission.

  4. Change in psychosocial and behavioral characteristics associated with C-tactile (CT) sensitivity assessed using standardized questionnaires with total and/or subscale questionnaire scores.

    Psychosocial and behavioral characteristics will be assessed using the Touch Experiences and Attitudes Questionnaire - short version (TEAQ-s), Brief COPE, UCLA Loneliness Scale, Experiences in Close Relationships - Short Form (ECR-S), and State-Trait Anxiety Inventory (STAI). These questionnaires assess social touch experiences and attitudes, coping strategies, loneliness and social isolation, attachment anxiety and avoidance, and state/trait anxiety, respectively. The outcome measures are the total and/or subscale questionnaire scores, calculated according to the scoring procedures of each instrument. Changes in these scores will be assessed across repeated measurements over time.

    Time frame: Baseline (approximately 2-3 months before departure); Month 1, Month 4, Month 7, Month 10, and Month 12 during the Antarctic winter-over; 6 months post-mission; and 2 years post-mission.

  5. Change in behavioral and psychosocial adaptation associated with C-tactile (CT) sensitivity assessed using the 15-item ICE-Psychosocial Monitoring Scale with scores on a Visual Analog Scale (VAS-score 0-10).

    Psychosocial adaptation during isolation and confinement will be assessed using the 15-item VAS-based ICE-Psychosocial Monitoring Scale. The scale assesses physical touch deprivation/contact need, social contact and interpersonal connection, situational/temporal loneliness, attachment and separation distress, and somatic self-soothing/physical regulation. Changes in VAS-based scores will be assessed across repeated measurements over time.

    Time frame: Baseline (approximately 2-3 months before departure); monthly during the Antarctic winter-over; 6 months post-mission; and 2 years post-mission.

  6. Change in tactile sensory performance associated with C-tactile (CT) sensitivity measured with the Brain Gauge Tactile Reaction Time Test (TRTT) using reaction-time and discrimination outcomes.

    Tactile sensory performance will be assessed using the Brain Gauge TRTT, a mouse-like device that delivers gentle tactile vibrations to the fingertips. The test battery includes simple reaction time, amplitude discrimination, temporal order judgment, and duration discrimination. Time-related outcomes will be expressed in milliseconds (ms). Changes in reaction-time and discrimination measures will be assessed across repeated measurements over time.

    Time frame: Baseline (approximately 2-3 months before departure); Month 1, Month 4, Month 7, Month 10, and Month 12 during the Antarctic winter-over; 6 months post-mission; and 2 years post-mission.

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Walker SC, Trotter PD, Swaney WT, Marshall A, Mcglone FP. C-tactile afferents: Cutaneous mediators of oxytocin release during affiliative tactile interactions? Neuropeptides. 2017 Aug;64:27-38. doi: 10.1016/j.npep.2017.01.001. Epub 2017 Jan 19. PubMed 28162847 ↗
  • McGlone F, Wessberg J, Olausson H. Discriminative and affective touch: sensing and feeling. Neuron. 2014 May 21;82(4):737-55. doi: 10.1016/j.neuron.2014.05.001. PubMed 24853935 ↗
  • Van Puyvelde M, Gijbels D, Van Caelenberg T, Smith N, Bessone L, Buckle-Charlesworth S, Pattyn N. Living on the edge: How to prepare for it? Front Neuroergon. 2022 Dec 14;3:1007774. doi: 10.3389/fnrgo.2022.1007774. eCollection 2022. PubMed 38235444 ↗
  • Butti N, Ferrari E, Oldrati V, Biffi E, Gagliardi C, Romaniello R, Strazzer S, Borgatti R, Urgesi C. News insights into social cognition in Williams syndrome from a comprehensive assessment and a virtual reality task. Sci Rep. 2024 Nov 14;14(1):28020. doi: 10.1038/s41598-024-79289-z. PubMed 39543275 ↗
  • Ackerley R, Backlund Wasling H, Liljencrantz J, Olausson H, Johnson RD, Wessberg J. Human C-tactile afferents are tuned to the temperature of a skin-stroking caress. J Neurosci. 2014 Feb 19;34(8):2879-83. doi: 10.1523/JNEUROSCI.2847-13.2014. PubMed 24553929 ↗

Individual participant data

Plan to share: No — Individual participant data are not planned to be shared with researchers outside the study consortium and sponsoring organizations. Study findings will be disseminated through scientific publications and presentations.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Feb 2031, 52 months later.

Of 17 observational studies under Social Isolation, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 44. This study's planned 52 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 7, 2026
First posted
Oct 5, 2026
StartEst.
Oct 2026
Primary completionEst.
Feb 2031
CompletionEst.
Feb 2031
Last update
Oct 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 5, 2026
Show all 1 update
  1. Oct 5, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07858240
Collaborators
Belgium: Belgian Federal Science Policy Office (BELSPO), European Space Agency, Institut Polaire Français Paul-Emile Victor (IPEV)
Responsible party
Sponsor
First posted
Oct 5, 2026
Start date
Oct 2026 (estimated)
Primary completion
Feb 2031 (estimated)
Completion
Feb 2031 (estimated)
Last update
Oct 5, 2026

Study contacts

Martine Van Puyvelde, Professor
Contact
Martine.Van.Puyvelde@vub.be
0032 495 239 543
Susannah Walker, Professor
Contact
S.C.Walker@ljmu.ac.uk
+44 1519046309

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion